acute hepatic porphyria

Alnylam's RNAi therapy Givlaari shows lasting effect one year into treatment, new data show
Fierce Pharma
Tue, 06/30/20 - 10:51 am
Alnylam
RNAi
Givlaari
acute hepatic porphyria
3 Rare Disease Drug Launches to Watch in 2020
Motley Fool
Sat, 01/4/20 - 07:38 pm
Global Blood Therapeutics
sickle cell disease
Oxbryta
Novartis
SCD
Adakveo
Alnylam
Givlaari
acute hepatic porphyria
FDA
Alnylam's givosiran reduces mean porphyria attacks by 74% in Phase III
BioCentury
Fri, 04/12/19 - 11:33 pm
Alnylam
FDA
givosiran
acute hepatic porphyria
Data in Hand, Alnylam To Seek OK For Second RNAi Drug
Xconomy
Wed, 03/6/19 - 10:07 am
Alnylam
RNAi
FDA
acute hepatic porphyria
givosiran
Alnylam shares drop 1.8% on new FDA approval strategy for rare disease drug
Marketwatch
Mon, 10/15/18 - 12:05 pm
Alnylam
FDA
givosiran
acute hepatic porphyria